We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Saliva Test Detects GHB and Alcohol Poisonings

By LabMedica International staff writers
Posted on 19 Jan 2016
Print article
Image: Differential mobility spectra extracted from the GC-DMS response surface for 1,3-propandiol (D) and GHB (E) (Photo courtesy of Loughborough University).
Image: Differential mobility spectra extracted from the GC-DMS response surface for 1,3-propandiol (D) and GHB (E) (Photo courtesy of Loughborough University).
Image: The Sionex microanalyzer trace chemical detection system (Photo courtesy of Sionex Corporation).
Image: The Sionex microanalyzer trace chemical detection system (Photo courtesy of Sionex Corporation).
A saliva-based test has been developed that offers the potential to screen for poisons commonly associated with the cheap or imitation manufacture of alcohol, and γ-hydroxybutyric acid, the so-called “date rape” drug GHB.

Treatment of poisoning from the consumption of ethanol and the management of the intoxicated patient represents a significant burden on many health services. Further, poisoning from the consumption of other alcohols, notably methanol and ethylene glycol, occurs sporadically and from time to time outbreaks occur where food, drink or medicines are contaminated, resulting in significant mortality.

Scientists at Loughborough University (UK) and the University of Cordoba (Spain) added to the fresh saliva of volunteers and used a polydimethylsiloxane (PDMS) oral sampler to extract methanol, ethanol, ethylene glycol, 1,3-propandiol and γ-hydroxybutyric acid. The compounds were detected using gas chromatography-differential mobility spectrometry (GC-DMS). The extracted compounds were recovered by thermal desorption, isolated by gas chromatography and detected with differential mobility spectrometry, operating with a programmed dispersion field.

Calibration of the DMS under optimized conditions was undertaken using gas chromatography to introduce known on-column masses of the analytes injected in a solution of dichloromethane. The DMS used in the study was a planar device (SDP-1, Sionex Corporation, Bedford, MA, USA). Once the analytes had been added, the saliva standards were homogenized. Immediately after this had been done, a PDMS-coated titanium cartridge was removed from its sealed thermal desorption tube and placed into the vial, which was then sealed immediately.

C.L. Paul Thomas, PhD, a professor of Analytical Science, and coauthor of the study, said, “Many people attending accident and emergency departments have some kind of alcohol-related issue, particularly at the weekends. We're aiming to develop a test that is as simple as taking temperature with a thermometer that detects when patients are more than just drunk. We were surprised at the ease at which we could detect γ-hydroxybutyric acid. It's both a polar and acidic molecule, but it turned out to be easy to detect, even at the low concentrations we were studying.” The scientists are now working on running trials of their test in a clinical setting, on patients in emergency departments. The study was published on January 8, 2016, in the Journal of Breath Research.

Related Links:

Loughborough University 
University of Cordoba 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.